New Drug R&D:Enterprises entering the phase I, II and III clinical trials of new drugs will be rewarded up to 3 million yuan, 5 million yuan and 10 million yuan respectively; for those who entrust local institutions to carry out clinical trials, the amount of reward will be increased by another 50%. The district level is awarded 100% as the municipal level.
Industrialization of New Drug Certificates:The highest award at the municipal and district levels is 74 million yuan, and the highest reward for new drug registration approval is 2 million yuan; The highest reward for drugs that pass FDA certification is 2 million yuan, and the highest reward for new drugs overseas listing is 5 million yuan.
Medical Devices: enterprises that have obtained Class II or Class III medical device registration certificates, the highest rewards are 5 million yuan and 8 million yuan respectively at the municipal and district levels .